No problem. Appreciate the update.
It is strange that the Q&A has remained so stale for so long, which is an observation we both have had since the last time you posted some of Bob's email responses.
RE: China, the translation part was the easy part, which is not surprising it is done (and likely, has been done for quite some time now). But it is a bit disappointing that SCRC has still not submitted the formal package for regulatory approval yet. Until they do, the 60-90 clock won't even begin to start ticking.
RE: RapiMeds not being on shelves in HK yet, I think what would be helpful to know is how long it takes to (1) manufacture, and (2) ship overseass. It has been only 11 days since SCRC announced the first order for HK, so I'm not surprised it's not yet on the shelves. BUT, if it is still not on the shelves by the end of APR, then that would be eyebrow-raising, IMO.
RE: PIMD, it is curious that there was no 8K (or at least simply a PR) if the PIMD deal had actually closed.
Hopefully, the 10K will shed light on these matters along with providing clarity on the overall extent of dilution from ALL sources (i.e. issuances of restricted stock), not simply from notes.
News 
Market Data 
Discover 
